To better evaluate the prognostic value of EPHA4 in breast cancer, we also assessed the association of EPHA4 mRNA levels and patients outcomes using GOBO online database and relapse-free survival (RFS) as an end-point. Here, EPHA4 is linked to breast carcinoma.